Fasiglifam 25 mg BID vs 50 mg QD
Clinical trial NCT01982253 · TERMINATED
Trial details
- NCT number
- NCT01982253
- Sponsor
- Takeda
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-01-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.